Results 31 to 40 of about 305,673 (272)
Journal of International Medical Research, 2019 Objectives We investigated the role of long non-coding (lnc) RNA-NEF (neighboring enhancer of FoxA2), a characterized oncogene in cancer biology, in postmenopausal osteoporosis and its diagnostic and prognostic value in this disease.
Xiaoyong Ma +9 more
doaj +1 more source
Examination of Oxidative Stress Markers in Women with Postmenopausal Osteoporosis
Türk Osteoporoz Dergisi, 2018 Objective: Postmenopausal osteoporosis a disease with increased fracture tendency in the bones based upon reduced bone mineral density. Oxidative stress is an important risk factor for osteoporosis.
Okan Dikker +3 more
doaj +1 more source
Osteoporosis in postmenopausal women
Canadian Family Physician, 2021 How effective are bisphosphonates and denosumab for preventing fractures in postmenopausal women? Bisphosphonates and denosumab are similarly effective. Over 1 to 4 years, bisphosphonates or denosumab provide an absolute reduction of about 0.5% to 1.0% for hip fractures, 1.5% to 3 ...
Samantha, Moe +2 more
openaire +2 more sources
Denosumab versus romosozumab for postmenopausal osteoporosis treatment
Scientific Reports, 2021 Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment.
T. Kobayakawa +5 more
semanticscholar +1 more source
Health Expectations, 2023 Introduction Osteoporosis is a significant clinical and public health concern worldwide. Despite the impact of this condition on women's lives, most studies have focused on its clinical manifestations, drug efficacy, and medical treatment.
Faiza Al Zadjali +3 more
doaj +1 more source
Endocrine Practice, 2020 Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols for the
Pauline M. Camacho +13 more
semanticscholar +1 more source
International Journal of Endocrinology, 2013 Objective. To demonstrate the role of Wnt/β-catenin canonical pathway in postmenopausal osteoporosis by evaluating serum β-catenin levels in patients with postmenopausal osteoporosis and analyzing their possible relationship with serum OPG, RANKL, the ...
Xiao-Juan Xu +6 more
doaj +1 more source
Science Advances, 2021 Biomimetic nanodecoys reconstruct the osteoclast/osteoblast balance to treat postmenopausal osteoporosis.
Yang Zhou +7 more
semanticscholar +1 more source
Journal of Orthopaedic Surgery and Research, 2021 Background Biochemical markers of bone turnover (BTMs), such as the bone alkaline phosphatase (bALP), procollagen type I N propeptide (PINP), serum cross-linked C-telopeptides of type I collagen (bCTx), and urinary cross-linked N-telopeptides of type I ...
Filippo Migliorini +5 more
semanticscholar +1 more source
Stem cell research & therapeutics, 2021 As one of the most common chronic diseases in the world, osteoporosis occurs especially in postmenopausal women. Circular RNAs (circRNAs) are emerging as major drivers in human disease.
F. Zhi +5 more
semanticscholar +1 more source